Abstract
Objectives: We performed a systematic review and meta-regression analysis of randomized control trials to investigate the association between response to initial treatment and survival outcomes in patients with newly diagnosed multiple myeloma (MM). Methods: Response outcomes included complete response (CR) and the combined outcome of CR or very good partial response (VGPR), while survival outcomes were overall survival (OS) and progression-free survival (PFS). We used random-effect meta-regression models and conducted sensitivity analyses based on definition of CR and study quality. Results: Seventy-two trials were included in the systematic review, 63 of which contributed data in meta-regression analyses. There was no association between OS and CR in patients without autologous stem cell transplant (ASCT) (regression coefficient:.02, 95% confidence interval [CI] −0.06, 0.10), in patients undergoing ASCT (−.11, 95% CI −0.44, 0.22) and in trials comparing ASCT with non-ASCT patients (.04, 95% CI −0.29, 0.38). Similarly, OS did not correlate with the combined metric of CR or VGPR, and no association was evident between response outcomes and PFS. Sensitivity analyses yielded similar results. Conclusions: This meta-regression analysis suggests that there is no association between conventional response outcomes and survival in patients with newly diagnosed MM.
Original language | English (US) |
---|---|
Pages (from-to) | 563-568 |
Number of pages | 6 |
Journal | European Journal of Haematology |
Volume | 98 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2017 |
Keywords
- complete response
- meta-regression analysis
- multiple myeloma
- survival
- systematic review
ASJC Scopus subject areas
- Hematology